Side-by-side comparison

Compare investment strategies

Cali Nevada Short-Biased Stocks vs Short Innovation (SARK) on Overbought QQQ

At a glance

The headline numbers each source publishes, lined up. Hover a number for its exact definition.

These strategies report performance on different (Hypo, OOS). Live and composite results come from real accounts; out-of-sample, hypothetical and model results don't. Compare return and risk with care.

—

0.0%

22.9%

27.0%Best

—

8.4%

0.59

2.93Best

-45.5%

-2.4%Best

Each source uses its own scale

25(Heart Attack Index (Collective2))

—

Inception

2022-12-04

—

44%Best

40%

Growth of $10,000

Each line starts at $10,000 on the first date all of them share, using the strategy's own published history. Bases are labelled and never mixed within a line.

Cali Nevada Short-Biased StocksHypoup 142.5%
S&P 500 ETFup 79.9%

No published history to chart: Short Innovation (SARK) on Overbought QQQ.

Every published figureShow 43 attributes

Each row is one exact variant (window and basis), so a value appears only where a source publishes it.

Classification

AI categories (Composer)

—

cash/t‑bills, daily rebalance, inverse etf, mean-reversion, nasdaq/tech timing, tactical

Asset classes / instruments

stocks

equities

Leaderboard views (Collective2)

old_timers

—

Market-relative

Alpha vs S&P 500, strategy life (hypothetical model account)

0.08

—

Beta vs S&P 500, strategy life (hypothetical model account)

-0.16

—

Correlation to S&P 500, strategy life (hypothetical model account)

-0.07

—

Returns

Annual return compounded, strategy life (hypothetical model account)

22.90%

—

Annualized return since inception (Lighthorse, daily, hypothetical)

23.43%

—

Return, 1 month (hypothetical model account)

2.14%

—

Return, 3 months (hypothetical model account)

3.06%

—

Return, 6 months (hypothetical model account)

4.13%

—

Return, last 365 days (Lighthorse, daily, hypothetical)

-5.38%

—

Return, out-of-sample period (annualized) (out-of-sample)

—

27.02%

Return, out-of-sample period (cumulative) (out-of-sample)

—

10.90%

Return, trailing 1 month (out-of-sample)

—

0.34%

Return, trailing 1 year (out-of-sample)

—

0.00%

Return, trailing 3 months (out-of-sample)

—

0.95%

Trading activity

Average leverage

0.56

—

Average position time

28,547

—

Maximum daily leverage

3.36

—

Number of trades

203

—

Percent of trades profitable

55.94%

—

Profit factor

1.46

—

Win:loss ratio

1.46

—

Risk metrics

Calmar ratio, out-of-sample period (out-of-sample)

—

11.43

Maximum drawdown since inception (Lighthorse, daily, hypothetical)

-45.49%

—

Maximum drawdown, last 365 days (Lighthorse, daily, hypothetical)

-19.25%

—

Maximum drawdown, out-of-sample period (out-of-sample)

—

-2.36%

Maximum drawdown, strategy life (hypothetical model account)

-45.50%

—

Sharpe ratio since inception (Lighthorse, daily, hypothetical)

0.54

—

Sharpe ratio, last 365 days (Lighthorse, daily, hypothetical)

-0.19

—

Sharpe ratio, out-of-sample period (out-of-sample)

—

2.93

Sharpe ratio, strategy life (hypothetical model account)

0.59

—

Sortino ratio, last 365 days (Lighthorse, daily, hypothetical)

-0.29

—

Sortino ratio, strategy life (hypothetical model account)

1.06

—

Standard deviation, out-of-sample period (out-of-sample)

—

8.35%

Volatility since inception (Lighthorse, daily, hypothetical)

47.21%

—

Volatility, last 365 days (Lighthorse, daily, hypothetical)

27.44%

—

Risk score

Heart Attack Index (Collective2)

—

Construction

Rebalance frequency

—

daily

Identity

Strategy age

1,408

—

Cost & access

Subscription price per month

$99

—

Suggested minimum capital

$25k

—

Compare investment strategies

At a glance

Growth of $10,000

What they say: stated rules

What they hold

Do the holdings back the rules?

Costs, access & sources

Compare investment strategies

At a glance

Growth of $10,000

What they say: stated rules

What they hold

Do the holdings back the rules?

Costs, access & sources